AIP
OM icon

Ahrens Investment Partners’s Outset Medical OM Stock Holding History

Ahrens Investment Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$2.76K Buy
+10
New +$3.67K ﹤0.01% 850
2022
Q3 		– Sell
-10
Closed -$2K – 673
2022
Q2 		$2K Buy
10
+3
+43% +$1.29K ﹤0.01% 885
2022
Q1 		$5K Hold
7
– – ﹤0.01% 860
2021
Q4 		$5K Buy
+7
New +$5.18K ﹤0.01% 883

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

Ahrens Investment Partners's OM Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Outset Medical (OM) in Q1 2023: 10 shares worth $2.76K. The stake represents ﹤0.01% of the portfolio and ranks #850 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in OM as recently as Q2 2022.

Ahrens Investment Partners first reported a position in OM in Q4 2021 and has held it in 4 quarters since. The position peaked at $5K in Q1 2022. 162 funds tracked by Wall St. Rank hold OM as of Q1 2023.

  • Ahrens Investment Partners held 10 shares of Outset Medical worth $2.76K as of Q1 2023.
  • Outset Medical was a new Ahrens Investment Partners position in Q1 2023.
  • Outset Medical made up ﹤0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #850 holding.
  • Ahrens Investment Partners first reported a position in Outset Medical in Q4 2021 and has held it in 4 quarters since.
  • Ahrens Investment Partners's Outset Medical position peaked at $5K in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Outset Medical as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.